# EDGAR Filing Document

**Accession Number:** 0001509745
**File Stem:** 0001104659-25-114086
**Filing Date:** 2025-11
**Character Count:** 4182
**Document Hash:** 1ca8bf3def1f5e13ff431ba812036982
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-114086.hdr.sgml**: 20251119

**ACCESSION NUMBER**: 0001104659-25-114086

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20251119

**DATE AS OF CHANGE**: 20251119

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CYPHERPUNK TECHNOLOGIES INC.
- **CENTRAL INDEX KEY:** 0001509745
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 274412575
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37990
- **FILM NUMBER:** 251499370

**BUSINESS ADDRESS:**
- **STREET 1:** 47 THORNDIKE STREET
- **STREET 2:** SUITE B1-1
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02142
- **BUSINESS PHONE:** 617 252 4343

**MAIL ADDRESS:**
- **STREET 1:** 47 THORNDIKE STREET
- **STREET 2:** SUITE B1-1
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02142

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LEAP THERAPEUTICS, INC.
- **DATE OF NAME CHANGE:** 20160818

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dekkun Corp
- **DATE OF NAME CHANGE:** 20110107

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 14A**

Proxy Statement Pursuant to Section 14(a) of<br> the Securities Exchange Act of 1934 (Amendment No.)

Filed by the Registrant ⌧

Filed by a Party other than the Registrant ◻

Check the appropriate box:

---

| | |
|:---|:---|
| ◻ | Preliminary Proxy Statement |
| ◻ | **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** |
| ◻ | Definitive Proxy Statement |
| ⌧ | Definitive Additional Materials |
| ◻ | Soliciting Material under §240.14a-12 |

---

![](tm2531760d1_defa14aimg01.jpg)

**Cypherpunk Technologies Inc.**

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

⌧ No fee required. <br> ◻ Fee paid previously with preliminary materials. <br> ◻ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

---

| | |
|:---|:---|
| ![](tm2531760d1_defa14aimg02.jpg) | YOUR VOTE IS IMPORTANT - PLEASE VOTE YOUR SHARES TODAY RE: Reminder of Special Meeting of Shareholders Dear Fellow Shareholder, We hope this message finds you well. We hope that you all saw the exciting announcement that Leap Therapeutics, Inc. is now Cypherpunk Technologies Inc., reflecting our expanded mission to support privacy enabling technologies, participate in the Zcash ecosystem, and acquire ZEC for our digital asset treasury. This is a reminder that we will hold a special meeting of stockholders on December 15, 2025, at 11:00 a.m. Eastern Time. Your Vote is Very Important! As a valued shareholder, your input plays a crucial role in shaping the future of our company, regardless of the size of your investment. Key Items Up for Vote: 1. Approval to increase authorized shares. To provide the company with flexibility for future financing and corporate activities, supporting strategic growth. 2. Approval of grant of authority to the Board to effect a reverse stock split, within a range of 1-for-5 to 1-for-20 To provide the company with flexibility for future financing and corporate activities, supporting strategic growth. 3. Adoption of the 2025 Equity Incentive Plan To continue attracting, retaining, and incentivizing talent which is critical to the company's progress. 4. Approval of the private placement issuance Approval is necessary to permit the company to issue shares in excess of 19.99% upon the exercise of certain warrants issued in the October 2025 private placement. The Board of Directors recommends a vote FOR all proposals as described in your proxy materials. If you have not yet voted, we strongly encourage you to do so as soon as possible by calling 888.742.1305 Monday through Friday, from 9 AM to 5 PM Eastern Time. Thank you for your continued support of Cypherpunk. Onward, Doug Onsi Chief Executive Officer and President |

---